Cell to Induce X-Linked Immunodeficiency B and Synergizes with B Cell Receptor Signals Mitogen-Activated Protein Kinase Activation Positive Signaling Through CD72 Induces
暂无分享,去创建一个
S. Estus | R. Flavell | R. Davis | H. Wu | S. Bondada | C. Venkataraman | Chen Dong | Hsin-jung Wu
[1] M. Ikawa,et al. The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. , 2000, Immunity.
[2] M. Matsumoto,et al. Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. , 2000, Immunity.
[3] R. Davis,et al. Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.
[4] S. Tomita,et al. BLNK is associated with the CD72 / SHP‐1 / Grb2 complex in the WEHI231 cell line after membrane IgM cross‐linking , 2000, European journal of immunology.
[5] Christopher C. Goodnow,et al. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis , 2000, Nature.
[6] T. Adachi,et al. CD72 Negatively Regulates Signaling Through the Antigen Receptor of B Cells1 , 2000, The Journal of Immunology.
[7] Gunther Hartmann,et al. Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells1 , 2000, The Journal of Immunology.
[8] M. Gold. Intermediary signaling effectors coupling the B-cell receptor to the nucleus. , 2000, Current topics in microbiology and immunology.
[9] N. Baumgarth,et al. CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. , 1999, Immunity.
[10] E. Gelfand,et al. Differential activation and regulation of mitogen‐activated protein kinases through the antigen receptor and CD40 in human B cells , 1999, European journal of immunology.
[11] E. Wagner,et al. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development , 1999, Current Biology.
[12] R. Flavell,et al. Defective T cell differentiation in the absence of Jnk1. , 1998, Science.
[13] T. Kurosaki,et al. Involvement of Guanosine Triphosphatases and Phospholipase C-γ2 in Extracellular Signal–regulated Kinase, c-Jun NH2-terminal Kinase, and p38 Mitogen-activated Protein Kinase Activation by the B Cell Antigen Receptor , 1998, The Journal of experimental medicine.
[14] T. Kurosaki,et al. Different Protein Tyrosine Kinases Are Required for B Cell Antigen Receptor–mediated Activation of Extracellular Signal–Regulated kinase, c-Jun NH2-terminal Kinase 1, and p38 Mitogen-activated Protein Kinase , 1998, The Journal of experimental medicine.
[15] R. Flavell,et al. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. , 1998, Immunity.
[16] J. Cambier,et al. Interleukin-4 overcomes the negative influence of cyclic AMP accumulation on antigen receptor stimulated B lymphocytes. , 1998, Molecular immunology.
[17] T. Pawson,et al. The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1 , 1998, Current Biology.
[18] A. Satterthwaite,et al. Btk function in B cell development and response. , 1998, Seminars in immunology.
[19] F. Hobbs,et al. Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.
[20] C. Turck,et al. BLNK: a central linker protein in B cell activation. , 1998, Immunity.
[21] E. Krebs,et al. A comparison of signaling requirements for apoptosis of human B lymphocytes induced by the B cell receptor and CD95/Fas. , 1998, Journal of immunology.
[22] M. Reth,et al. The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. , 1998, Journal of immunology.
[23] T. Kurosaki,et al. Requirement of SH2-containing Protein Tyrosine Phosphatases SHP-1 and SHP-2 for Paired Immunoglobulin-like Receptor B (PIR-B)–mediated Inhibitory Signal , 1998, The Journal of experimental medicine.
[24] N. Muthusamy,et al. Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes. , 1998, Journal of immunology.
[25] Ching-shih Chen,et al. CD72‐mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3‐kinase , 1998, European journal of immunology.
[26] D. Parker,et al. Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway. , 1998, Journal of Immunology.
[27] W. Kolch,et al. Epstein–Barr virus latent membrane protein‐1 triggers AP‐1 activity via the c‐Jun N‐terminal kinase cascade , 1997, The EMBO journal.
[28] A. Ashworth,et al. A role for JNK/SAPK in proliferation, but not apoptosis, of IL-3-dependent cells , 1997, Current Biology.
[29] K. Rajewsky,et al. In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death , 1997, Cell.
[30] T. Kurosaki,et al. Deletion of SHIP or SHP-1 Reveals Two Distinct Pathways for Inhibitory Signaling , 1997, Cell.
[31] P. Youinou,et al. Modulation of CD72 by ligation of B cell receptor complex molecules on CD5+ B cells. , 1997, International immunology.
[32] K. Brorson,et al. xid affects events leading to B cell cycle entry. , 1997, Journal of immunology.
[33] G. Crabtree,et al. Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. , 1997, Immunity.
[34] M. Inaoki,et al. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. , 1997, Immunity.
[35] G. Köhler,et al. CD22 is a negative regulator of B-cell receptor signalling , 1997, Current Biology.
[36] K. Schuebel,et al. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product , 1997, Nature.
[37] R. Perlmutter,et al. CD22 regulates thymus-independent responses and the lifespan of B cells , 1996, Nature.
[38] S. Bondada,et al. CD5-Mediated Negative Regulation of Antigen Receptor-Induced Growth Signals in B-1 B Cells , 1996, Science.
[39] A. Miller,et al. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. , 1996, Immunity.
[40] M. Neuberger,et al. Hyperresponsive B Cells in CD22-Deficient Mice , 1996, Science.
[41] C. Nobes,et al. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways , 1996, Current Biology.
[42] M. Gold,et al. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. , 1996, Journal of immunology.
[43] G. Bishop,et al. CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. , 1996, Journal of immunology.
[44] Wei Wei Wu,et al. Induction of cell cycle regulatory proteins in anti-immunoglobulin- stimulated mature B lymphocytes , 1996, The Journal of experimental medicine.
[45] S. Korsmeyer,et al. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2. , 1996, Journal of immunology.
[46] J. Woodgett,et al. Cross‐linking CD40 on B cells preferentially induces stress‐activated protein kinases rather than mitogen‐activated protein kinases. , 1996, The EMBO journal.
[47] T. Mak,et al. Immunoglobulin-mediated signal transduction in B cells from CD45- deficient mice , 1996, The Journal of experimental medicine.
[48] Philip R. Cohen,et al. PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.
[49] N. Solvason,et al. Murine CD38: an immunoregulatory ectoenzyme. , 1995, Immunology today.
[50] F. Alt,et al. Defective B cell development and function in Btk-deficient mice. , 1995, Immunity.
[51] D. Fearon,et al. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. , 1995, Science.
[52] E. Krebs,et al. The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] J. Monroe,et al. Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. , 1995, Journal of immunology.
[54] J. Gordon,et al. B-cell signalling via the C-type lectins CD23 and CD72. , 1994, Immunology today.
[55] J. Kehrl,et al. Differential expression of a novel protein kinase in human B lymphocytes. Preferential localization in the germinal center. , 1994, The Journal of biological chemistry.
[56] M. Cobb,et al. MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network. , 1994, Advances in cancer research.
[57] J. Banchereau,et al. The CD40 antigen and its ligand. , 1994, Annual review of immunology.
[58] J. Cambier,et al. Signal transduction by the B cell antigen receptor and its coreceptors. , 1994, Annual review of immunology.
[59] M. Neuberger,et al. Association of CD22 with the B cell antigen receptor , 1993, European journal of immunology.
[60] R. Geahlen,et al. CD22 associates with the human surface IgM-B-cell antigen receptor complex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[61] M. Gold,et al. Selective activation of p42 mitogen-activated protein (MAP) kinase in murine B lymphoma cell lines by membrane immunoglobulin cross-linking. Evidence for protein kinase C-independent and -dependent mechanisms of activation. , 1992, The Biochemical journal.
[62] W. Fridman,et al. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. , 1992, Science.
[63] C. June,et al. Biochemical analysis of the immune B cell defect in xid mice. , 1991, Journal of immunology.
[64] N. Muthusamy,et al. Differential regulation of surface Ig- and Lyb2-mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two different receptors linked to phosphatidylinositol hydrolysis in murine B cells. , 1991, Journal of immunology.
[65] H. Coste,et al. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. , 1991, The Journal of biological chemistry.
[66] M. Harnett,et al. Analysis of signaling via surface immunoglobulin receptors on b cells from cba/n mice , 1989, European journal of immunology.
[67] W. Paul,et al. Differential induction of class II gene expression in murine pre-B-cell lines by B-cell stimulatory factor-1 and by antibodies to B-cell surface antigens. , 1988, The Journal of molecular and cellular immunology : JMCI.
[68] E. C. Snow,et al. The phosphatidylinositol response is an early event in the physiologically relevant activation of antigen-specific B lymphocytes. , 1987, Cellular immunology.
[69] W. Paul,et al. Regulation of Growth and Proliferation in B Cell Subpopulations , 1982, Immunological reviews.